Evidence map›Paper›PMID 37443600›Full record

ArticleDiagnostics (Basel, Switzerland)2023

ExtRanFS: An Automated Lung Cancer Malignancy Detection System Using Extremely Randomized Feature Selector.

Nitha V R, Vinod Chandra S S

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nitha V RDepartment of Computer Science, University of Kerala, Thiruvananthapuram 695581, India.ORCID 0000-0002-9352-4860
Vinod Chandra S SDepartment of Computer Science, University of Kerala, Thiruvananthapuram 695581, India.ORCID 0000-0003-2298-1906

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is an abnormality where the body's cells multiply uncontrollably. The disease can be deadly if not detected in the initial stage. To address this issue, an automated lung cancer malignancy detection (ExtRanFS) framework is developed using transfer learning. We used the IQ-OTH/NCCD dataset gathered from the Iraq Hospital in 2019, encompassing CT scans of patients suffering from various lung cancers and healthy subjects. The annotated dataset consists of CT slices from 110 patients, of which 40 were diagnosed with malignant tumors and 15 with benign tumors. Fifty-five patients were determined to be in good health. All CT images are in DICOM format with a 1mm slice thickness, consisting of 80 to 200 slices at various sides and angles. The proposed system utilized a convolution-based pre-trained VGG16 model as the feature extractor and an Extremely Randomized Tree Classifier as the feature selector. The selected features are fed to the Multi-Layer Perceptron (MLP) Classifier for detecting whether the lung cancer is benign, malignant, or normal. The accuracy, sensitivity, and F1-Score of the proposed framework are 99.09%, 98.33%, and 98.33%, respectively. To evaluate the proposed model, a comparison is performed with other pre-trained models as feature extractors and also with the existing state-of-the-art methodologies as classifiers. From the experimental results, it is evident that the proposed framework outperformed other existing methodologies. This work would be beneficial to both the practitioners and the patients in identifying whether the tumor is benign, malignant, or normal.

Indexed as

deep learningextratree classifierfeature extractionfeature selectionlung cancer malignancy detectiontransfer learning

Identifiers

PMID37443600
PMCPMC10340584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.